These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36969018)

  • 1. Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma.
    Sun H; Wang H; Wang Y; Zhong W; Meng Y; Lv Z; Guo W; Han B
    Front Oncol; 2023; 13():1129065. PubMed ID: 36969018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
    Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
    Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
    Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
    J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
    Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
    BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
    Wang H; Du PC; Wu MC; Cong WM
    Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
    Yuan L; Feng J; Zhang Y; Lu C; Xu L; Liang C; Liu Z; Mao F; Xiang Y; Wang W; Wang K; Cheng S
    Eur J Surg Oncol; 2023 Jul; 49(7):1226-1233. PubMed ID: 36739252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
    Huang Q; Lin K; Wang L; Zeng J; Liu H; Ding Z; Zeng Y; Liu J
    Cancer Manag Res; 2020; 12():9183-9195. PubMed ID: 33061610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma.
    Wang H; Yu H; Qian YW; Cao ZY; Wu MC; Cong WM
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):232-239. PubMed ID: 33455865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index.
    Xu JX; Xing WT; Peng YC; Chen YY; Qi LN
    Future Oncol; 2022 Jun; 18(17):2113-2125. PubMed ID: 35266821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification.
    Zeng JS; Zeng JX; Huang Y; Liu JF; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):482-489. PubMed ID: 35934610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion.
    Qiu Y; Yang Y; Wang T; Shen S; Wang W
    Front Oncol; 2022; 12():831614. PubMed ID: 35795039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
    Luo L; Shan R; Cui L; Wu Z; Qian J; Tu S; Zhang W; Xiong Y; Lin W; Tang H; Zhang Y; Zhu J; Huang Z; Li Z; Mao S; Li H; Hu Z; Peng P; He K; Li Y; Liu L; Shen W; He Y
    United European Gastroenterol J; 2023 Mar; 11(2):228-241. PubMed ID: 36905230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
    Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
    Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection.
    Liu F; Guo X; Dong W; Zhang W; Wei S; Zhang S; Zhu X; Zhou W; Zhang J; Liu H
    Int J Biol Sci; 2020; 16(16):3210-3220. PubMed ID: 33162826
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.
    Chen MY; Juengpanich S; Hu JH; Topatana W; Cao JS; Tong CH; Lin J; Cai XJ
    World J Gastroenterol; 2020 Mar; 26(10):1042-1055. PubMed ID: 32205995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.